After losing their father and grandfather to Alzheimer’s, these brothers began researching functional and hallucinogenic mushrooms

Chris and Joe Claussen witnessed their father suffer when his own father was diagnosed with Alzheimer’s disease while they were young. Later, at the young age of 65, their father was diagnosed with the disorder that affects memory, brain function, and behavior.

Joe stated, “We witnessed the progression from little issues to a major catastrophe.”

The brothers had witnessed the conclusion of the disease, and they hunted for explanations. The possible medical benefits of mushrooms attracted them. They found slight improvements in their father’s abilities after implementing dietary adjustments. It was unfortunately too late to reverse the progression of the sickness.

Chris stated, “The basic truth is that if you wait too long to start taking care of your brain, there is not much you can do.” “You must begin 20 to 30 years before to the onset of symptoms.”

The brothers’ risk of Alzheimer’s is elevated.

The brothers opted to undergo genetic testing to determine their Alzheimer’s risk. It was discovered that both individuals carry the APOE4 gene, which doubles or triples the chance of acquiring Alzheimer’s disease. For the brothers, this knowledge was crucial information.

Chris stated, “It shouldn’t be frightening; it should be a guidance.”

They began following a plan for a healthy brain that includes a ketogenic diet and medicinal mushrooms such as Lion’s Mane. Both individuals reported experiencing physical and cognitive gains. This persuaded them that they were on the right track, and they launched First Person.

Chris stated, “We wanted to spread the word that the time to take care of your brain is now.”

Investigating the effects of microdosing and mushrooms

First Person manufactures mental health supplements derived from functional mushrooms. Functional mushrooms, such as Lion’s Mane, do not contain psychoactive substances that are prohibited in the United States.

The Claussens, however, feel that these chemicals are equally as crucial to brain health. First Person is undertaking research on the legality of hallucinogenic mushrooms in Jamaica. Both Claussens feel that some kind of legalization in the United States is inevitable, and they intend for their research to support this position.

Joe stated, “We’re examining these chemicals and considering standardizing dosage.”

Joe stated that these substances have been utilized for millennia, particularly in Asian societies. The US drug policy has stigmatized them, but Western scientists are beginning to see their potential. Microdosing, the technique of consuming extremely small amounts of psychedelics, is supported by a robust grassroots movement, with everyone from mothers to veterans praising its benefits.

The brothers wish to protect their own families from calamity.

The Claussens feel that their future is not predetermined despite their hereditary danger. They believe Alzheimer’s can be prevented via dietary and lifestyle modifications. Research indicates that they may be onto something: Up to forty percent of dementia cases could be averted with lifestyle modifications such as limiting alcohol use and maintaining a healthy blood pressure.

Chris stated, “This entails making a few minor adjustments that are not terribly difficult.”

This will assist the entire family avoid future heartache.

Chris stated, “It impacts everyone if you can’t take care of yourself.”